Company: BIAF
Filing Date: 2025-09-17
Form Type: 8-K
Source: 0001493152-25-013892
Chunk: 2

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-17
Form: 8-K
Item: Item 5.03
Chunk 2
---
 would have otherwise received fractional shares who will receive cash in lieu of such fractional
shares.

The
Company’s Common Stock will continue to trade on the Nasdaq Stock Market LLC under the existing symbol “ BIAF”, but
the security has been assigned a new CUSIP number (09076W307).

The
foregoing description of the Certificate of Amendment does not purport to be complete and is qualified in its entirety by reference to
the full text of the Certificate of Amendment, which is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated by reference
herein.

Item
7.01 Regulation FD Disclosure